Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Allergan
Allergan
Allergan ex-CEO Saunders takes board seat at BridgeBio
Fierce Biotech
Fri, 06/26/20 - 09:54 am
Brent Saunders
Pharma CEOs
Allergan
BridgeBio
Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact
Fierce Biotech
Fri, 06/19/20 - 11:24 am
Assembly Biosciences
microbiome
Allergan
AbbVie
M&A
Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns
Endpoints
Thu, 06/18/20 - 10:39 am
AbbVie
Allergan
M&A
FTC
Breast Implant Makers Land in Hot Water with FDA
Medical Devices and Diagnostics Industry
Thu, 05/14/20 - 10:52 pm
FDA
breast implants
devices
Allergan
Ideal Implant
Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray
Endpoints
Mon, 05/11/20 - 10:36 am
Oyster Point Pharma
dry eye disease
OC-01
Allergan
Restasis
Shire
Xiidra
AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go
Fierce Pharma
Wed, 05/6/20 - 12:09 am
AbbVie
Allergan
M&A
FTC
AbbVie CEO: Don't worry, Allergan's aesthetics clients still have money—and 'strong desire' for treatment
Fierce Pharma
Fri, 05/1/20 - 12:57 pm
AbbVie
Allergan
M&A
aesthetics
pandemic
COVID-19
A Covid-19 threat to business acquisitions
EP Vantage
Thu, 04/2/20 - 11:57 am
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical
AbbVie and Allergan Sign Divestiture Consent Decree with FTC, Move Closer to Finalizing Merger
BioSpace
Thu, 03/19/20 - 12:01 am
AbbVie
Allergan
FTC
M&A
AbbVie, Allergan merger may face regulatory delay due to COVID-19: report
Fierce Pharma
Tue, 03/17/20 - 11:32 pm
AbbVie
Allergan
FTC
M&A
COVID-19
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Pharmaforum
Wed, 03/11/20 - 10:45 am
Amgen
Allergan
biosimilars
Roche
rituximab
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
BioSpace
Mon, 03/9/20 - 11:10 pm
biosimilars
Amgen
Allergan
Roche
Rituxan
Bristol-Myers Squibb
ozanimod
risdiplam
Biomarin
valrox
FDA approves Allergan’s biodegradable glaucoma implant drug
PM Live
Fri, 03/6/20 - 11:46 pm
Allergan
Durysta
FDA
glaucoma
AbbVie and Allergan finally set (rough) date for wedding as one parent agrees to the match
Endpoints
Wed, 03/4/20 - 10:54 am
AbbVie
Allergan
M&A
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Endpoints
Thu, 02/27/20 - 11:46 pm
Biohaven
FDA
migraines
Nurtec
Allergan
AbbVie
Ubrelvy
Allergan accused of misleading CoolTone marketing in new lawsuit from BTL
Fierce Pharma
Wed, 02/26/20 - 10:31 am
Allergan
BTL
CoolTone
devices
EmSculpt
In final report, ICER appears to have a change of heart on new acute migraine therapies
Endpoints
Tue, 02/25/20 - 10:40 am
ICER
migraines
Biohaven
Allergan
ubrogepant
rimegepant
Eli Lilly
Lasmiditan
Allergan Sued by BTL Over False Advertising Claims Regarding Muscle-Toning Product
Motley Fool
Sat, 02/22/20 - 11:26 pm
Allergan
BTL
advertising
Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst
Fierce Pharma
Fri, 02/21/20 - 10:49 am
Allergan
Botox
migraines
physicians
neurologists
CGRPs
Allergan targets filler-prone millennials with new Juvederm lip campaign
Fierce Pharma
Wed, 02/12/20 - 10:48 am
Allergan
Juvederm
millennials
DTC ads
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »